Figure 4.

Pretreatment CBC counts in patients with SCN. Data are shown for patients in SCN Group 6 (Table 1). Symbols show mean CBC values for the period from 3 years before the start of treatment through the day that treatment was started (▪ or •) and 95% confidence limits (error bars), for patients in subgroups A to D defined by G-CSF dose at 6 months and ANC response during the subsequent year (for further information about subgroups A to D, see Figure 3 and Table 2). These analyses incorporated precision weights determined by the number of patient-specific CBC values available prior to treatment. Panels show (A) hemoglobin, (B) platelets, (C) eosinophils, (D) basophils, (E) monocytes, (F) lymphocytes, and (G) pretreatment ANC.